- Home
- INCR vs QNTM Comparison
INCR vs QNTM Comparison
Compare INCR & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- QNTM
- Stock Information
- Founded
- INCR 1994
- QNTM 1998
- Country
- INCR Israel
- QNTM Canada
- Employees
- INCR N/A
- QNTM N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- QNTM
- Sector
- INCR Health Care
- QNTM
- Exchange
- INCR Nasdaq
- QNTM NYSE
- Market Cap
- INCR 84.5M
- QNTM 69.3M
- IPO Year
- INCR N/A
- QNTM N/A
- Fundamental
- Price
- INCR $1.55
- QNTM $18.56
- Analyst Decision
- INCR
- QNTM
- Analyst Count
- INCR 0
- QNTM 0
- Target Price
- INCR N/A
- QNTM N/A
- AVG Volume (30 Days)
- INCR 24.5K
- QNTM 408.5K
- Earning Date
- INCR 08-15-2025
- QNTM 08-13-2025
- Dividend Yield
- INCR N/A
- QNTM N/A
- EPS Growth
- INCR N/A
- QNTM N/A
- EPS
- INCR N/A
- QNTM N/A
- Revenue
- INCR $65,575,323.00
- QNTM N/A
- Revenue This Year
- INCR $69.54
- QNTM N/A
- Revenue Next Year
- INCR $41.75
- QNTM N/A
- P/E Ratio
- INCR N/A
- QNTM N/A
- Revenue Growth
- INCR N/A
- QNTM N/A
- 52 Week Low
- INCR $1.17
- QNTM $2.70
- 52 Week High
- INCR $2.62
- QNTM $38.25
- Technical
- Relative Strength Index (RSI)
- INCR 60.11
- QNTM 50.64
- Support Level
- INCR $1.48
- QNTM $15.88
- Resistance Level
- INCR $1.56
- QNTM $24.32
- Average True Range (ATR)
- INCR 0.06
- QNTM 3.58
- MACD
- INCR 0.01
- QNTM -1.07
- Stochastic Oscillator
- INCR 80.99
- QNTM 13.59
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.